Congress approves $100 million in prostate cancer research funding through DoD

When it passed the Omnibus appropriations bill for the financial year 2018 at the end of last week, Congress increased funding for prostate cancer research from $80 to $100 million through the Department of Defense’s Congressionally Directed Medical Research Program (CDRMP). … READ MORE …

Funding for DoD CDMRP prostate cancer research in 2014

According to the Report of the U.S. House of Representatives’ Committee on Appropriations (see p. 273) it is currently proposed that the Prostate Cancer Research Program of the Department of Defense’s Congressionally Directed Medical Research Program will again receive $80 million in funding for the financial year 2014. … READ MORE …

It’s time to badger your Congressman/Congresswoman again …

As the annual Defense appropriations cycle starts once again, The “New” Prostate Cancer InfoLink encourages all you US-based prostate cancer patients and other US-based voters to e-mail your Congressman or Congresswoman and ask them to support prostate cancer research funding through the “Dear Colleague” letter being circulated by Representative Pete King in the House. … READ MORE …

Current status of proposed funding for the DoD PCRP in FY 2012

An amendment  to the Defense Appropriations Act offered by Congressman Cliff Stearns (R, FL) on the floor of the House of Representatives yesterday has added back $16 million to the Department of Defense’s Prostate Cancer Research Program (PCRP). The amendment was passed by a voice vote and supported by members of both political parties. … READ MORE …

What is the DoD PCRP? And why does it matter?

DoD PCRP stands for the Congressionally mandated Department of Defense Prostate Cancer Research Program — and it is the only US government-sponsored initiative that dedicates funding specifically to prostate cancer research. (Similar DoD cancer programs provide dedicated funding for research into breast, lung, colon, and ovarian cancers.) … READ MORE …